
Profitability, historical returns, and peer comparisons.
According to Medpace Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is 99.76%. This represents a change of 292.73% compared to the average of 25.40% of the last 4 quarters.
The mean historical ROE of Medpace Holdings, Inc. over the last ten years is 33.47%. The current 99.76% ROE has changed 198.08% with respect to the historical average. Over the past ten years (40 quarters), MEDP's ROE was at its highest in in the June 2025 quarter at 52.37%. The ROE was at its lowest in in the December 2016 quarter at -0.00%.
Average
33.47%
Median
18.56%
Minimum
2.20%
Maximum
98.27%
Discovering the peaks and valleys of Medpace Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 253.44%
Maximum Annual ROE = 98.27%
Minimum Annual Increase = -204.80%
Minimum Annual ROE = 2.20%
| Year | ROE | Change |
|---|---|---|
| 2025 | 98.27% | 100.61% |
| 2024 | 48.98% | -3.19% |
| 2023 | 50.60% | -20.32% |
| 2022 | 63.50% | 232.77% |
| 2021 | 19.08% | 5.77% |
| 2020 | 18.04% | 30.46% |
| 2019 | 13.83% | 11.44% |
| 2018 | 12.41% | 59.73% |
| 2017 | 7.77% | 253.44% |
| 2016 | 2.20% | -204.80% |
The current ROE of Medpace Holdings, Inc. (MEDP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
65.95%
5-year avg
56.09%
10-year avg
33.47%
Medpace Holdings, Inc.’s ROE is less than IQVIA Holdings Inc. (21.82%), less than ICON Public Limited Company (4.85%), greater than Charles River Laboratories International, Inc. (-7.72%), greater than Fortrea Holdings Inc. (-12.81%), less than WuXi AppTec Co., Ltd. (30.77%), less than Joinn Laboratories(China)Co.,Ltd. (13.10%), less than Pharmaron Beijing Co., Ltd. (10.93%), less than WuXi XDC Cayman Inc (14.00%),
| Company | ROE | Market cap |
|---|---|---|
| 21.82% | $43.13B | |
| 4.85% | $15.95B | |
| -7.72% | $16.66B | |
| -12.81% | $1.94B | |
| 30.77% | $63.53B | |
| 13.10% | $30.30B | |
| 10.93% | $63.17B | |
| 14.00% | $83.64B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medpace Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Medpace Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Medpace Holdings, Inc.'s ROE?
How is the ROE calculated for Medpace Holdings, Inc. (MEDP)?
What is the highest ROE for Medpace Holdings, Inc. (MEDP)?
What is the 3-year average ROE for Medpace Holdings, Inc. (MEDP)?
What is the 5-year average ROE for Medpace Holdings, Inc. (MEDP)?
How does the current ROE for Medpace Holdings, Inc. (MEDP) compare to its historical average?